医学
再狭窄
狼牙棒
靶病变
动脉切除术
支架
病变
切割气球
放射科
穿孔
经皮
揭穿
经皮冠状动脉介入治疗
气球
外科
血管成形术
临床终点
传统PCI
心肌梗塞
随机对照试验
内科学
材料科学
癌症
冲孔
冶金
卵巢癌
作者
Florin-Leontin Lazar,Alfonso Ielasi,Bernardo Cortese
出处
期刊:Minerva cardiology and angiology
[Edizioni Minerva Medica]
日期:2022-03-28
卷期号:70 (6)
被引量:1
标识
DOI:10.23736/s2724-5683.22.06061-6
摘要
Coronary lesions predilatation with semicompliant (SC) or non-compliant balloons (NC) may be insufficient to obtain an optimal stent expansion, which can lead to in-stent restenosis or thrombosis. Moreover, increasing evidence supporting an optimal lesion preparation is mandatory when drug coated balloons (DCB) are used. To this extent, more "aggressive tools" such as cutting/scoring balloons, atherectomy or lithotripsy may play an important role and improve outcomes.We enrolled 78 consecutive patients from March 2020 to October 2020 with calcific/fibrotic or ostially-located lesions, which were prepared using scoring balloons, in addition to SC/NC balloons and other plaque modification strategies. The final treatment consisted in either stent or DCB usage. The primary endpoint was the rate of clinically-driven target lesion revascularization. Secondary endpoints entailed the procedural success and the individual rates of major adverse cardiac events (MACE) at 12 months.Most of the patients had left main (LM) or ostial lesions, 65% of them being moderate/severely calcified, with further debulking strategies being required in 15 (19.2%) patients (rotational atherectomy, 3.8% or coronary intravascular lithotripsy, 15.3%). A high-rate of DCB usage was reported. Angiographic and procedural success was obtained in 77 and 76 patients, respectively. We encountered one vessel perforation, which was sealed with a covered stent, without consequence. During follo- up, we observed only 6 MACE, 6 target lesion revascularizations (TLR) and 2 cardiovascular deaths.Among patients with high complexity and calcific lesions, an optimal lesion preparation using a dedicated scoring balloon was associated with low clinical events at mid-term follow-up and may be considered to improve immediate procedural success rate.
科研通智能强力驱动
Strongly Powered by AbleSci AI